NCT06818110

Brief Summary

The CardioFit Trial: The feasibility, safety and tolerability of an exercise training programme in patients with severe aortic stenosis prior to aortic valve replacement surgery: A feasibility trial To investigate if a Structured Responsive Exercise Training Programme (SRETP) delivered before aortic valve replacement (AVR) in patients with severe aortic stenosis is feasible, safe, and tolerable. Fitter patients have better surgical outcomes. Exercising post AVR surgery has been well documented and supported through cardiac rehabilitation programmes. However, there is limited evidence investigating exercising patients preoperatively, in part related to safety considerations in patients with severe aortic stenosis. If undertaking a SRETP before AVR in patients with severe aortic stenosis is shown to be feasible and safe, it provides a prehabilitation opportunity to enhance physical fitness with the aim of improving surgical outcomes. Therefore, this trial will investigate whether SRETP (Prehabilitation) delivered before AVR in patients with severe aortic stenosis is safe \& feasible.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2025

Completed
Last Updated

February 10, 2025

Status Verified

November 1, 2024

Enrollment Period

9 months

First QC Date

November 27, 2024

Last Update Submit

February 5, 2025

Conditions

Keywords

ExercisePrehabilitationAortic valve replacementAortic stenosisCardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Feasibility Outcomes

    1. Adherence to the intervention ≥75% 2. Tolerability of the intervention (minutes completed during the interval training) of ≥75% 3. Adverse Events to the intervention (defined as occurring during or up to 30-minutes post exercise training)

    Baseline up to surgery

Secondary Outcomes (3)

  • Endurance time

    Baseline up to surgery

  • Change in objectively measured cardiopulmonary exercise testing variables

    Baseline up to surgery

  • Health-related quality of life

    Baseline up to surgery

Study Arms (1)

An in-hospital Structured Responsive Exercise-Training Programme (SRETP)

OTHER

Participants will participate in a structured, responsive, exercise training programme (SRETP) on a cycle ergometer. This training programme has been used in numerous international clinical trials, in several patient cohorts including cancer and lung disease. The training programme will involve short periods of exercise at a high intensity interspersed with short periods of exercise at a moderate intensity. This mode of exercise training is termed aerobic high-intensity interval training (HIIT). Exercise intensities during the interval exercise training program are specific to each participant and will be derived from the CPET. Moderate-intensity exercise is recognised as exercise below the anaerobic threshold. Participants will exercise at 80% of the work rate achieved at the anaerobic threshold (80%AT) for moderate-intensity exercise. High-intensity exercise is recognised as 50% of the difference between the "V" ̇O2 at the anaerobic threshold and the "V" ̇O2 peak (50%∆).

Other: Exercise

Interventions

The supervised exercise-training sessions will last \<1 hour, and exercise-training intensities will be individually tailored to each participant using the results from their CPET. Participants will be screened prior to each session to ensure that it is safe to perform exercise. Exercise training will involve repeated exercise bouts of 3 minutes at a moderate exercise intensity (80%AT) followed by 2 minutes of exercise at a high-intensity (50%∆) for a predetermined amount of time. Five minutes of freewheel cycling will be performed at the start and end of the protocol for a warm-up and cool-down. Exercise sessions can be terminated by the participant at any time. Participants will have continuous ECG and SpO2 monitoring throughout the training session. Vital signs will be taken before (some during) and after each training session.

Also known as: An in-hospital Structured Responsive Exercise-Training Programme (SRETP)
An in-hospital Structured Responsive Exercise-Training Programme (SRETP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants may enter the study if ALL of the following apply:
  • Age ≥ 18 years old
  • Severe aortic stenosis with a multidisciplinary team (MDT) plan for elective, aortic valve replacement
  • At least 14 days until planned to come in (TCI) date.

You may not qualify if:

  • Diagnosis of critical aortic stenosis defined as a mean gradient of ≥60mmHg or Vmax ≥5 m/s
  • Presyncope/syncope due to aortic stenosis
  • Unstable angina/indication for urgent surgery
  • Malignant arrhythmias
  • Known pregnancy
  • Patients declining surgery
  • Patients weight exceeds 160kg
  • Patients unable to give informed consent
  • Currently participating in another interventional clinical trial (although this will be reviewed on a case-by-case basis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hopsitals Southampton NHS FT

Southampton, SO16 6YD, United Kingdom

Location

MeSH Terms

Conditions

Aortic Valve StenosisMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2024

First Posted

February 10, 2025

Study Start

January 28, 2025

Primary Completion

October 10, 2025

Study Completion

December 10, 2025

Last Updated

February 10, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in sickle cell anemia. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
"Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis."
Access Criteria
Completion of trial

Locations